SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Sun Pharmaceutical Industries
Sun Pharmaceutical Industries
BSE: 524715|NSE: SUNPHARMA|ISIN: INE044A01036|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Feb 09, 16:00
854.25
18.15 (2.17%)
VOLUME 239,190
LIVE
NSE
Feb 09, 15:59
854.05
18.4 (2.2%)
VOLUME 2,340,243
News on Sun Pharmaceutical Industries
Select Year: 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
FPIs trim stake in 30 Nifty stocks in Q3

7.13 pm | 09 Feb 2016 |  Source: PTI

FPIs, which pulled out over Rs 3,200 crore from stock markets in the October-December quarter, flow in equities may continue to remain weak in the fou...

Buy Century Textiles, Sun Pharma: Kunal Bothra 

2.37 pm | 09 Feb 2016 |  Source: CNBC-TV18

Kunal Bothra, Head of Advisory at LKP Securities is of the view that one may buy Century Textiles and Sun Pharma....

Prefer Alembic Pharma: Mehraboon Irani 

4.03 pm | 08 Feb 2016 |  Source: CNBC-TV18

Mehraboon Irani of Nirmal Bang Securities is of the view that one may prefer Alembic Pharmaceuticals from the pharma space....

Prefer pharma, Alembic Pharma looks interesting: Dipan Mehta 

1.14 pm | 08 Feb 2016 |  Source: CNBC-TV18

Dipan Mehta, Member at BSE & NSE is of the view that there are opportunities in pharma stocks and feels that Alembic Pharma looks interesting....

Stay invested in Sun Pharma, says Ashish Kyal 

3.10 pm | 05 Feb 2016 |  Source: CNBC-TV18

Ashish Kyal of wavesstrategy.com is of the view that one may stay invested in Sun Pharma....

Positive on largecap pharma stocks, cement: Deven Choksey 

12.15 pm | 05 Feb 2016 |  Source: CNBC-TV18

Deven Choksey of KRChoksey Investment Managers has a positive view on largecap pharma stocks and the cement space....

Sun Pharma Advanced Research's Q3 net loss widens to Rs 41 cr

8.00 pm | 03 Feb 2016 |  Source: PTI

The company had posted a net loss of Rs 18.91 crore for the corresponding period of the previous fiscal, SPARC said in a BSE filing. ...

Six in Sixty: Stocks you should keep on your radar 

2.49 pm | 03 Feb 2016 |  Source: CNBC-TV18

CNBC-TV18's Ekta Batra lists out stocks that you should focus on – Crompton Greaves, HUL, Cairn India, Vedanta, Hindalco, ICICI Bank, Sun Pharma....

DLF, Tata Comm, Majesco in focus post Q3 nos 

8.44 am | 03 Feb 2016 |  Source: CNBC-TV18

Stocks likely to be in focus are: DLF, Crompton Greaves, United Breweries, Tata Communications, Sun Pharmaceutical Industries, Amara Raja Batteries, A...

Stocks in news: Crompton, DLF, Adani Enterprises, Sun TV, Uflex

8.20 am | 03 Feb 2016 |  Source: CNBC-TV18

Crompton Greaves | DLF | Adani Enterprises | GAIL | Sun TV Network | Tata Communications | Torrent Power | United Breweries | RPG Life | Tube Investme...

Six in Sixty: Stocks you should keep on your radar 

3.07 pm | 02 Feb 2016 |  Source: CNBC-TV18

CNBC-TV18's Mangalam Maloo lists out stocks that you should focus on – ICICI Bank, Axis Bank, Kotak Mahindra Bank, State Bank of India, Tech Mahindr...

Sun Pharma gains; launches Imatinib Mesylate in US market

9.57 am | 02 Feb 2016 |  Source: Moneycontrol.com

The company's subsidiary has received final approval for Imatinib Mesylate from Food and Drug Administration (FDA) in December 2015. ...

Stocks in news: Tata Motors, Hero, Sun Pharma, Wipro, Aban, SBT

8.20 am | 02 Feb 2016 |  Source: CNBC-TV18

Tata Motors | TVS Motor | DLF | Sun Pharma | Wipro | Tech Mahindra | Hero Motocorp | Balaji Telefilms | Maharashtra Seamless | Gujarat Siddhi | Shalim...

Sun hopes cut-price generic Gleevec will win third of US market

8.01 am | 02 Feb 2016 |  Source: Reuters

Gleevec, or imatinib mesylate, costs up to about USD 90,000 annually in the United States, implying Sun's price could be roughly USD 60,000. Gleevec p...

Sun completes sale of 2 Ranbaxy divisions to Strides

8.45 pm | 01 Feb 2016 |  Source: PTI

All the necessary formalities for closure of the said transaction have been completed and the aforesaid transaction has been successfully closed on Fe...

Buy Infosys, Sun Pharma; sell Just Dial: Ashish Kyal 

3.16 pm | 01 Feb 2016 |  Source: CNBC-TV18

Ashish Kyal of wavesstrategy.com is of the view that one can buy Infosys and Sun Pharma and advises selling Just Dial....

Aurobindo, Lupin, L&T, JSW Steel should be on radar today 

9.20 am | 01 Feb 2016 |  Source: CNBC-TV18

Stocks likely to be in the focus are: Larsen and Toubro, JSW Steel, Aurobindo Pharma, Lupin, Shriram Transport Finance Corporation, Jagran Prakashan, ...

Six in Sixty: Stocks you should keep on your radar 

2.57 pm | 29 Jan 2016 |  Source: CNBC-TV18

CNBC-TV18's Ekta Batra lists out stocks that you should focus on – NTPC, Yes Bank, Vedanta, L&T, Sun Pharma, ICICI Bank, Maruti Suzuki, Bharti Airte...

Sun Pharma may test Rs 885-900, says Yogesh Mehta 

1.15 pm | 29 Jan 2016 |  Source: CNBC-TV18

Yogesh Mehta of Motilal Oswal Securities is of the view that Sun Pharma may test Rs 885-900....

Sell JSW Steel, Sun Pharma may hit Rs 860: Rajat Bose 

1.14 pm | 29 Jan 2016 |  Source: CNBC-TV18

Rajat Bose of rajatkbose.com recommends selling JSW Steel and feels that Sun Pharma may hit Rs 860....

1 2 3 4 5 6 7 8 9 10Next »
Quick Links for Sun Pharmaceutical Industries
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.